Page 72 - குறிப்பு தொடர்பாக முன்னோக்கி பார்க்கிறது அறிக்கைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குறிப்பு தொடர்பாக முன்னோக்கி பார்க்கிறது அறிக்கைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குறிப்பு தொடர்பாக முன்னோக்கி பார்க்கிறது அறிக்கைகள் Today - Breaking & Trending Today

Blueprint Medicines Presents Preclinical Data Highlighting Broad Precision Therapy Research Pipeline at AACR Annual Meeting 2021


Blueprint Medicines Presents Preclinical Data Highlighting Broad Precision Therapy Research Pipeline at AACR Annual Meeting 2021
Preclinical data presented at AACR highlight four precision therapies with first- or best-in-class potential
IND application cleared by FDA for BLU-945, a triple-mutant EGFR inhibitor for EGFR-driven lung cancer
Nominated BLU-222, a selective and potent CDK2 inhibitor development candidate, for cyclin E-aberrant cancers
Blueprint Medicines to host investor conference call and webcast on Monday, April 12 at 8:00 a.m. ET
News provided by
Share this article
Share this article
CAMBRIDGE, Mass., April 10, 2021 /PRNewswire/ Blueprint Medicines Corporation (NASDAQ: BPMC) today announced data from multiple poster presentations highlighting the breadth of the company s precision therapy pipeline at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021. Collectively, the presentations, inc ....

United States , United Kingdom , Fouad Namouni , Blueprint Medicines Corporation , Research Development At Blueprint Medicines , Drug Administration , Exchange Commission , American Association For Cancer Research , Prnewswire Blueprint Medicines Corporation , Medicines Corporation , American Association , Cancer Research , Annual Meeting , Blueprint Medicine , Blueprint Medicines , Note Regarding Forward Looking Statements , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , வரைபடம் மருந்துகள் நிறுவனம் , ஆராய்ச்சி வளர்ச்சி இல் வரைபடம் மருந்துகள் , பரிமாற்றம் தரகு , அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி , மருந்துகள் நிறுவனம் ,

Heatherdale Resources Ltd.: Heatherdale Appoints Marilyne Lacasse, P.Geo as Vice-President, Exploration


Heatherdale Resources Ltd.: Heatherdale Appoints Marilyne Lacasse, P.Geo as Vice-President, Exploration
Heatherdale or the
Company ) (TSXV:HTR) is pleased to announce that Ms. Marilyne Lacasse, P.Geo has been appointed Vice-President, Exploration for the Company, effective April 1, 2020.
Ms. Lacasse is considered one of the most talented, young exploration geologists in the Pacific Northwest and we are very grateful for her acceptance of the position of Vice President, Exploration for our Company. said Rob McLeod, President and CEO of Heatherdale.
Her experience and strength in working safely in challenging geological terranes, track record for discovering mineralization and incorporation of new and innovative technologies are impressive. Her abilities and enthusiasm for exploration anywhere from advanced-stage resource expansion to greenfields project has enabled her to attract additional technical talent in both Alaska and Canada. ....

United States , British Columbia , Robert Mcleod , Rob Mcleod , Marilyne Lacasse , Geological Management Firm , University Of Quebec At Montreal , Heatherdale Resources Ltd , Company Mineral Resource , Exploration For The Company , Consulting Independent Of The Company , Venture Exchange , Regulation Services Provider , Hunter Dickinson Inc , Mining Ltd , Heatherdale Resources , Pacific Northwest , Vice President , Project Management , Outbounds Consulting , Project Manager , Red Mountain Underground Gold Project , New Gold , Northern Superior Resources , Professional Geologist , Qualified Person ,